CRSP
Price
$64.81
Change
+$1.04 (+1.63%)
Updated
Sep 30, 04:59 PM (EDT)
Capitalization
5.61B
29 days until earnings call
FHTX
Price
$4.89
Change
-$0.12 (-2.40%)
Updated
Sep 30, 04:59 PM (EDT)
Capitalization
274.74M
42 days until earnings call
Interact to see
Advertisement

CRSP vs FHTX

Header iconCRSP vs FHTX Comparison
Open Charts CRSP vs FHTXBanner chart's image
CRISPR Therapeutics AG
Price$64.81
Change+$1.04 (+1.63%)
Volume$27.03K
Capitalization5.61B
Foghorn Therapeutics
Price$4.89
Change-$0.12 (-2.40%)
Volume$3.45K
Capitalization274.74M
CRSP vs FHTX Comparison Chart in %
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. FHTX commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Buy and FHTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 01, 2025
Stock price -- (CRSP: $63.77 vs. FHTX: $5.01)
Brand notoriety: CRSP and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 87% vs. FHTX: 87%
Market capitalization -- CRSP: $5.61B vs. FHTX: $274.74M
CRSP [@Biotechnology] is valued at $5.61B. FHTX’s [@Biotechnology] market capitalization is $274.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while FHTX’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 5 bearish.
  • FHTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than FHTX.

Price Growth

CRSP (@Biotechnology) experienced а +2.69% price change this week, while FHTX (@Biotechnology) price change was +0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +12.63%, and the average quarterly price growth was +68.65%.

Reported Earning Dates

CRSP is expected to report earnings on Oct 29, 2025.

FHTX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.61B) has a higher market cap than FHTX($275M). CRSP YTD gains are higher at: 62.017 vs. FHTX (6.144). FHTX has higher annual earnings (EBITDA): -88.7M vs. CRSP (-533.5M). CRSP has more cash in the bank: 1.72B vs. FHTX (199M). FHTX has less debt than CRSP: FHTX (23.7M) vs CRSP (215M). CRSP has higher revenues than FHTX: CRSP (35M) vs FHTX (24.2M).
CRSPFHTXCRSP / FHTX
Capitalization5.61B275M2,040%
EBITDA-533.5M-88.7M601%
Gain YTD62.0176.1441,009%
P/E RatioN/AN/A-
Revenue35M24.2M145%
Total Cash1.72B199M865%
Total Debt215M23.7M907%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPFHTX
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVCFX16.12N/A
N/A
Victory Pioneer Disciplined Value C
CSPAX73.33N/A
N/A
American Funds SMALLCAP World 529A
NRIIX22.49N/A
N/A
Nuveen Real Asset Income I
GPROX16.36N/A
N/A
Grandeur Peak Global Reach Inv
IOGYX51.69N/A
N/A
Invesco Gold & Special Minerals R5

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with IPSC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+3.09%
IPSC - FHTX
47%
Loosely correlated
-1.87%
OCUL - FHTX
47%
Loosely correlated
N/A
NRIX - FHTX
45%
Loosely correlated
+3.92%
ERAS - FHTX
45%
Loosely correlated
+1.44%
CRSP - FHTX
45%
Loosely correlated
+3.41%
More